Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

NCT00000609 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2016-05-13

No results posted yet for this study

Summary

To compare conventional treatment of congestive heart failure (CHF) with two experimental interventions: amiodarone and an implantable cardioverter-defibrillator (ICD).

Conditions

Interventions

DRUG

amiodarone

DEVICE

defibrillators, implantable

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Kerry Lee · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Min Age
19 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-05-31
Completion
2005-04-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000609 on ClinicalTrials.gov